Scientists introduced a cell membrane biomimetic nanodrug platform termed MPB-3BP@CM nanoparticles (NPs). Notably, blocking CD47 with MPB-3BP@CM NPs enhanced the phagocytosis of colorectal cancer cells by macrophages.
[Signal Transduction and Targeted Therapy]